Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 10Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Pain, Postoperative 3Neurotoxicity Syndromes 3Melanoma 3Leukemia, Myeloid, Acute 3Brain Neoplasms 3Recurrence 2Ovarian Neoplasms 2Hemorrhage 2Chronic Pain 2Agnosia 2Vulvodynia 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Seizures 1Radiodermatitis 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1

Interventions

Ibandronic Acid 4Zoledronic Acid 3Tranexamic Acid 2ridaforolimus 1dinutuximab 1Sodium Pertechnetate Tc 99m 1Sodium Chloride 1Neutrons 1Fluoridation 1Fibrin Tissue Adhesive 1Diathermy 1Denosumab 1Cyproheptadine 1Cefazolin 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Bone Neoplasms × Sodium Chloride × Clear all
NCT04410042 2024-12-20

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

St. Jude Children's Research Hospital

Phase 3 Terminated
15 enrolled 13 charts
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡